Elizabeth Kidd

Radiation oncologist

Assistant Professor of Radiation Oncology at the Stanford University Medical Center

Radiation Oncology

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Medical Education: Washington University School Of Medicine (2005) MO

Residency: Washington University Dept of Radiation Oncology (06/30/2010) MO

Board Certification: Radiation Oncology, American Board of Radiology (2011)

Internship: Washington University School Of Medicine (06/20/2006) MO

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California.
Froment, M.-A., Gomez, S. L., Roux, A., DeRouen, M. C., & Kidd, E. A. (2014). Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California. Gynecologic oncology, 133(3), 409-415.

Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy
Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L., & Chang, D. T. (2013). Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(5), 983-991.

ACR APPROPRIATENESS CRITERIA (R) Management of Vaginal Cancer
Lee, L. J., Jhingran, A., Kidd, E., Cardenes, H. R., Elshaikh, M. A., & Gaffney, D. K. (2013). ACR APPROPRIATENESS CRITERIA (R) Management of Vaginal Cancer. ONCOLOGY-NEW YORK, 27(11), 1166-1173.

Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes
Hiniker, S. M., Roux, A., Murphy, J. D., Harris, J. P., Tran, P. T., & Kidd, E. A. (2013). Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes. GYNECOLOGIC ONCOLOGY, 131(2), 380-385.

Treatment approach and outcomes of vaginal melanoma.
Kirschner, A. N., Kidd, E. A., Dewees, T., & Perkins, S. M. (2013). Treatment approach and outcomes of vaginal melanoma. International journal of gynecological cancer , 23(8), 1484-1489.

ACR Appropriateness Criteria (R) Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva
Kidd, E., Moore, D., Varia, M. A., Gaffney, D. K., Elshaikh, M. A., & Cardenes, H. R. (2013). ACR Appropriateness Criteria (R) Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 36(4), 415-422.

Changes in cervical cancer FDG uptake during chemoradiation and association with response.
Kidd, E. A., Thomas, M., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2013). Changes in cervical cancer FDG uptake during chemoradiation and association with response. International journal of radiation oncology, biology, physics, 85(1), 116-122.

FDG-PET-based prognostic nomograms for locally advanced cervical cancer
Kidd, E. A., El Naqa, I., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2012). FDG-PET-based prognostic nomograms for locally advanced cervical cancer. GYNECOLOGIC ONCOLOGY, 127(1), 136-140.

ACR Appropriateness Criteria (R) Definitive Therapy for Early-Stage Cervical Cancer
Small, W., Strauss, J. B., Jhingran, A., Yashar, C. M., Cardenes, H. R., & Gaffney, D. K. (2012). ACR Appropriateness Criteria (R) Definitive Therapy for Early-Stage Cervical Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(4), 399-405.

RADIATION THERAPY FOR PILOCYTIC ASTROCYTOMAS OF CHILDHOOD
Mansur, D. B., Rubin, J. B., Kidd, E. A., King, A. A., Hollander, A. S., & Leonard, J. R. (2011). RADIATION THERAPY FOR PILOCYTIC ASTROCYTOMAS OF CHILDHOOD. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(3), 829-834.

CLINICAL OUTCOMES OF DEFINITIVE INTENSITY-MODULATED RADIATION THERAPY WITH FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY SIMULATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
Kidd, E. A., Siegel, B. A., Dehdashti, F., Rader, J. S., Mutic, S., & Grigsby, P. W. (2010). CLINICAL OUTCOMES OF DEFINITIVE INTENSITY-MODULATED RADIATION THERAPY WITH FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY SIMULATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 77(4), 1085-1091.

Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis
Kidd, E. A., Dehdashti, F., Siegel, B. A., & Grigsby, P. W. (2010). Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis. RADIOTHERAPY AND ONCOLOGY, 95(3), 288-291.

Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis
Kidd, E. A., Siegel, B. A., Dehdashti, F., Rader, J. S., Mutch, D. G., & Grigsby, P. W. (2010). Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis. JOURNAL OF CLINICAL ONCOLOGY, 28(12), 2108-2113.

Pelvic Lymph Node F-18 Fluorodeoxyglucose Uptake as a Prognostic Biomarker in Newly Diagnosed Patients With Locally Advanced Cervical Cancer
Kidd, E. A., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2010). Pelvic Lymph Node F-18 Fluorodeoxyglucose Uptake as a Prognostic Biomarker in Newly Diagnosed Patients With Locally Advanced Cervical Cancer. CANCER, 116(6), 1469-1475.

Cervical Cancer Histology and Tumor Differentiation Affect F-18-Fluorodeoxyglucose Uptake
Kidd, E. A., Spencer, C. R., Huettner, P. C., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2009). Cervical Cancer Histology and Tumor Differentiation Affect F-18-Fluorodeoxyglucose Uptake. CANCER, 115(15), 3548-3554.

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.
El Naqa, I., Grigsby, P., Apte, A., Kidd, E., Donnelly, E., & Deasy, J. O. (2009). Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern recognition, 42(6), 1162-1171.

Intratumoral metabolic heterogeneity of cervical cancer
Kidd, E. A., & Grigsby, P. W. (2008). Intratumoral metabolic heterogeneity of cervical cancer. CLINICAL CANCER RESEARCH, 14(16), 5236-5241.

The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
Kidd, E. A., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2007). The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. CANCER, 110(8), 1738-1744.

The efficacy of radiation therapy in the management of grade I astrocytomas
Kidd, E. A., Mansur, D. B., Leonard, J. R., Michalski, J. M., Simpson, J. R., & Perry, A. (2006). The efficacy of radiation therapy in the management of grade I astrocytomas. JOURNAL OF NEURO-ONCOLOGY, 76(1), 55-58.

Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer
Kidd, E. A., Yu, J. S., Li, X., Shannon, W. D., Watson, M. A., & McLeod, H. L. (2005). Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer. CLINICAL CANCER RESEARCH, 11(7), 2612-2619.